Dr. Wang’s primary research focus is the development of new technologies and methods for molecular analysis of diseases and biomedical research via advances in micro- and nano-scale sciences. He has contributed to developments in single-molecule fluorescence spectroscopy, microfluidics and nano-biosensors for genetic and epigenetic biomarker-based diagnostics of cancer, infectious disease and an array of other diseases. Wang also has taken the leading role in the development of quantum dot-fluorescence resonance energy transfer (QD-FRET) DNA nanosensors, which have been used to detect a variety of cancer biomarkers, including point mutations, DNA methylation and gene copy variations in clinical laboratories. In addition, he has pioneered the development of single molecule detection (SMD) technologies for biomarker screening. Wang is an inventor of 20 patents, and has authored > 150 research articles and delivered > 90 invited talks. He received the NSF CAREER Award in 2006, CSR Jorge Heller Award in 2007, ASGR Excellence in Research Award in 2007, JALA Ten Award in 2011, and JHU Discover Award in 2015.